Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001412678-12-000001
Filing Date
2012-01-09
Accepted
2012-01-09 16:50:07
Documents
1
Period of Report
2011-12-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 18915
  Complete submission text file 0001412678-12-000001.txt   20389
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4364 SOUTH ALSTON AVENUE DURHAM NC 27713
Business Address
Cato Allen Easley (Reporting) CIK: 0001412678 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54014 | Film No.: 12517958